| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasospasm, Intracranial | 19 | 2023 | 208 | 6.080 |
Why?
|
| Stroke | 92 | 2023 | 9981 | 5.770 |
Why?
|
| Brain Ischemia | 50 | 2023 | 3265 | 4.560 |
Why?
|
| Cerebrovascular Disorders | 13 | 2023 | 1504 | 4.130 |
Why?
|
| Vasoconstriction | 19 | 2023 | 597 | 3.610 |
Why?
|
| Cerebral Angiography | 23 | 2021 | 1285 | 2.560 |
Why?
|
| Vasculitis, Central Nervous System | 8 | 2022 | 42 | 2.390 |
Why?
|
| Headache Disorders, Primary | 7 | 2021 | 36 | 2.080 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 4 | 2023 | 53 | 2.080 |
Why?
|
| Ischemic Attack, Transient | 10 | 2022 | 935 | 2.050 |
Why?
|
| Intracranial Arteriosclerosis | 5 | 2022 | 138 | 1.980 |
Why?
|
| Cerebral Arterial Diseases | 5 | 2017 | 82 | 1.950 |
Why?
|
| Cerebral Infarction | 7 | 2020 | 1011 | 1.550 |
Why?
|
| Oxygen Inhalation Therapy | 9 | 2016 | 367 | 1.550 |
Why?
|
| Thrombectomy | 6 | 2023 | 680 | 1.360 |
Why?
|
| Cerebral Hemorrhage | 12 | 2020 | 2647 | 1.320 |
Why?
|
| Cerebral Arteries | 9 | 2013 | 494 | 1.300 |
Why?
|
| Puerperal Disorders | 4 | 2019 | 275 | 1.270 |
Why?
|
| Intracranial Arterial Diseases | 3 | 2019 | 22 | 1.160 |
Why?
|
| Muscle Weakness | 2 | 2020 | 413 | 1.120 |
Why?
|
| Paresis | 3 | 2021 | 179 | 1.050 |
Why?
|
| Cerebrovascular Circulation | 11 | 2020 | 2731 | 1.040 |
Why?
|
| Subarachnoid Hemorrhage | 8 | 2019 | 1018 | 1.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 16 | 2021 | 2737 | 0.960 |
Why?
|
| Hyperbaric Oxygenation | 4 | 2008 | 163 | 0.880 |
Why?
|
| Nervous System Diseases | 5 | 2022 | 1622 | 0.860 |
Why?
|
| Endocarditis | 3 | 2021 | 350 | 0.810 |
Why?
|
| Glycyrrhiza | 2 | 2011 | 11 | 0.790 |
Why?
|
| Neuroprotective Agents | 4 | 2019 | 941 | 0.780 |
Why?
|
| Takayasu Arteritis | 1 | 2022 | 96 | 0.760 |
Why?
|
| Intracranial Hemorrhages | 5 | 2021 | 855 | 0.710 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 126 | 0.700 |
Why?
|
| Venous Thrombosis | 4 | 2024 | 1239 | 0.660 |
Why?
|
| Heparin | 3 | 2021 | 1637 | 0.640 |
Why?
|
| Infarction, Middle Cerebral Artery | 8 | 2021 | 475 | 0.640 |
Why?
|
| Brain Diseases | 7 | 2021 | 1563 | 0.630 |
Why?
|
| Recurrence | 8 | 2023 | 8340 | 0.630 |
Why?
|
| Endovascular Procedures | 6 | 2023 | 1979 | 0.620 |
Why?
|
| Headache | 8 | 2023 | 1226 | 0.610 |
Why?
|
| Humans | 178 | 2024 | 744343 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 40 | 2021 | 35421 | 0.600 |
Why?
|
| Registries | 7 | 2018 | 8089 | 0.590 |
Why?
|
| Female | 120 | 2024 | 380194 | 0.590 |
Why?
|
| Brain | 31 | 2020 | 26385 | 0.580 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2021 | 500 | 0.560 |
Why?
|
| Hyperoxia | 5 | 2005 | 262 | 0.560 |
Why?
|
| Middle Aged | 85 | 2021 | 213383 | 0.560 |
Why?
|
| Male | 118 | 2023 | 350118 | 0.550 |
Why?
|
| Moyamoya Disease | 1 | 2019 | 238 | 0.540 |
Why?
|
| Brain Edema | 7 | 2016 | 617 | 0.540 |
Why?
|
| Vasomotor System | 1 | 2016 | 209 | 0.530 |
Why?
|
| Brain Infarction | 8 | 2023 | 299 | 0.520 |
Why?
|
| Tomography, X-Ray Computed | 21 | 2019 | 20129 | 0.520 |
Why?
|
| Eclampsia | 2 | 2021 | 58 | 0.510 |
Why?
|
| Emergencies | 1 | 2022 | 1170 | 0.510 |
Why?
|
| Migraine Disorders | 3 | 2017 | 1620 | 0.510 |
Why?
|
| Anticoagulants | 7 | 2023 | 4599 | 0.510 |
Why?
|
| Recovery of Function | 9 | 2021 | 2925 | 0.490 |
Why?
|
| International Cooperation | 4 | 2018 | 1420 | 0.490 |
Why?
|
| Muscle Strength | 1 | 2018 | 592 | 0.480 |
Why?
|
| Tissue Plasminogen Activator | 8 | 2016 | 1261 | 0.470 |
Why?
|
| Intracranial Thrombosis | 3 | 2024 | 113 | 0.470 |
Why?
|
| Renal Artery Obstruction | 1 | 2015 | 248 | 0.470 |
Why?
|
| Cerebral Veins | 3 | 2017 | 156 | 0.460 |
Why?
|
| Quality of Health Care | 4 | 2018 | 4371 | 0.460 |
Why?
|
| Pregnancy Complications | 3 | 2019 | 2861 | 0.450 |
Why?
|
| Carotid Stenosis | 4 | 2018 | 854 | 0.450 |
Why?
|
| Aged | 73 | 2023 | 163280 | 0.450 |
Why?
|
| Foramen Ovale, Patent | 2 | 2013 | 223 | 0.440 |
Why?
|
| Severity of Illness Index | 16 | 2020 | 15540 | 0.440 |
Why?
|
| Atrial Fibrillation | 5 | 2023 | 5034 | 0.440 |
Why?
|
| Unemployment | 1 | 2014 | 214 | 0.430 |
Why?
|
| India | 6 | 2019 | 2197 | 0.430 |
Why?
|
| Diagnosis, Differential | 15 | 2020 | 12959 | 0.420 |
Why?
|
| Acute Disease | 19 | 2022 | 7149 | 0.420 |
Why?
|
| Thrombolytic Therapy | 8 | 2021 | 2161 | 0.410 |
Why?
|
| Endarterectomy, Carotid | 2 | 2007 | 546 | 0.410 |
Why?
|
| Syndrome | 7 | 2016 | 3251 | 0.410 |
Why?
|
| Motor Cortex | 3 | 2018 | 986 | 0.410 |
Why?
|
| Constriction, Pathologic | 2 | 2013 | 1107 | 0.390 |
Why?
|
| Adult | 60 | 2022 | 214055 | 0.390 |
Why?
|
| Risk Factors | 26 | 2023 | 72290 | 0.380 |
Why?
|
| Treatment Outcome | 31 | 2023 | 63114 | 0.380 |
Why?
|
| Aged, 80 and over | 38 | 2021 | 57776 | 0.370 |
Why?
|
| Thromboembolism | 3 | 2013 | 986 | 0.370 |
Why?
|
| Coma | 6 | 2012 | 475 | 0.360 |
Why?
|
| Retrospective Studies | 34 | 2023 | 77449 | 0.360 |
Why?
|
| Carotid Artery, External | 1 | 2009 | 38 | 0.360 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2023 | 793 | 0.350 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2009 | 45 | 0.350 |
Why?
|
| Vascular System Injuries | 2 | 2023 | 250 | 0.350 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2002 | 0.340 |
Why?
|
| Oxygen | 8 | 2023 | 4189 | 0.320 |
Why?
|
| Eligibility Determination | 1 | 2011 | 403 | 0.310 |
Why?
|
| Frontal Lobe | 3 | 2018 | 1406 | 0.300 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2107 | 0.300 |
Why?
|
| Reperfusion | 4 | 2010 | 284 | 0.290 |
Why?
|
| Tomography Scanners, X-Ray Computed | 3 | 2014 | 168 | 0.290 |
Why?
|
| Patient Selection | 4 | 2020 | 4215 | 0.290 |
Why?
|
| Middle Cerebral Artery | 5 | 2020 | 264 | 0.290 |
Why?
|
| Blast Crisis | 1 | 2007 | 103 | 0.290 |
Why?
|
| Prognosis | 22 | 2022 | 29063 | 0.280 |
Why?
|
| Disease Progression | 12 | 2021 | 13284 | 0.270 |
Why?
|
| Collateral Circulation | 2 | 2021 | 287 | 0.270 |
Why?
|
| Postpartum Period | 2 | 2021 | 1086 | 0.270 |
Why?
|
| Vascular Diseases | 2 | 2005 | 1161 | 0.270 |
Why?
|
| Guillain-Barre Syndrome | 2 | 2005 | 120 | 0.260 |
Why?
|
| Psychotic Disorders | 1 | 2020 | 3046 | 0.260 |
Why?
|
| Hypothermia, Induced | 2 | 2008 | 752 | 0.260 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2022 | 585 | 0.260 |
Why?
|
| Spinal Puncture | 1 | 2007 | 281 | 0.250 |
Why?
|
| Pre-Eclampsia | 2 | 2021 | 1200 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2016 | 8949 | 0.250 |
Why?
|
| Wakefulness | 2 | 2010 | 1245 | 0.250 |
Why?
|
| Intracranial Embolism | 4 | 2020 | 202 | 0.250 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2012 | 333 | 0.240 |
Why?
|
| Time Factors | 13 | 2022 | 40075 | 0.240 |
Why?
|
| Predictive Value of Tests | 15 | 2020 | 15076 | 0.240 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 4 | 2020 | 292 | 0.240 |
Why?
|
| Disability Evaluation | 3 | 2021 | 1827 | 0.230 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 707 | 0.230 |
Why?
|
| Thrombosis | 3 | 2021 | 2968 | 0.230 |
Why?
|
| Warfarin | 3 | 2021 | 1496 | 0.230 |
Why?
|
| Bartonella Infections | 1 | 2003 | 22 | 0.220 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4931 | 0.220 |
Why?
|
| Magnetic Resonance Angiography | 6 | 2024 | 1442 | 0.220 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2024 | 103 | 0.220 |
Why?
|
| Upper Extremity | 3 | 2018 | 648 | 0.220 |
Why?
|
| Dementia, Vascular | 1 | 2004 | 128 | 0.220 |
Why?
|
| Pyramidal Tracts | 2 | 2015 | 256 | 0.220 |
Why?
|
| Prospective Studies | 20 | 2023 | 53288 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Carotid Artery Diseases | 3 | 2010 | 882 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Heart Arrest | 5 | 2012 | 1470 | 0.200 |
Why?
|
| Young Adult | 18 | 2020 | 56430 | 0.200 |
Why?
|
| Seizures | 3 | 2010 | 2859 | 0.200 |
Why?
|
| Hypoxia, Brain | 1 | 2002 | 133 | 0.200 |
Why?
|
| Thiazoles | 2 | 2021 | 1483 | 0.200 |
Why?
|
| Reflex | 1 | 2003 | 365 | 0.200 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 2029 | 0.200 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2002 | 152 | 0.190 |
Why?
|
| Mental Disorders | 1 | 2021 | 6600 | 0.190 |
Why?
|
| Embolism, Paradoxical | 1 | 2021 | 58 | 0.190 |
Why?
|
| Clinical Trials as Topic | 4 | 2014 | 7913 | 0.190 |
Why?
|
| Hyperglycemia | 2 | 2009 | 1373 | 0.180 |
Why?
|
| Chickenpox | 1 | 2001 | 131 | 0.180 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 1999 | 12 | 0.180 |
Why?
|
| Pregnancy | 6 | 2021 | 29144 | 0.180 |
Why?
|
| Clinical Protocols | 2 | 2018 | 1462 | 0.180 |
Why?
|
| Patient Transfer | 2 | 2020 | 761 | 0.180 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1999 | 65 | 0.180 |
Why?
|
| Immunologic Factors | 2 | 2020 | 1580 | 0.170 |
Why?
|
| Ankle Joint | 1 | 2003 | 411 | 0.170 |
Why?
|
| Confusion | 1 | 2021 | 275 | 0.170 |
Why?
|
| Encephalitis | 1 | 2003 | 423 | 0.170 |
Why?
|
| Delusions | 1 | 2021 | 300 | 0.170 |
Why?
|
| Long QT Syndrome | 1 | 2023 | 453 | 0.170 |
Why?
|
| After-Hours Care | 1 | 2020 | 102 | 0.170 |
Why?
|
| Quadriplegia | 2 | 2003 | 223 | 0.170 |
Why?
|
| Sleep | 2 | 2020 | 4623 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2022 | 374 | 0.160 |
Why?
|
| Social Planning | 1 | 2018 | 11 | 0.160 |
Why?
|
| Drug Administration Routes | 2 | 2016 | 153 | 0.160 |
Why?
|
| Hypertension | 6 | 2020 | 8480 | 0.160 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 354 | 0.150 |
Why?
|
| China | 3 | 2018 | 2248 | 0.150 |
Why?
|
| Adolescent | 19 | 2020 | 85781 | 0.150 |
Why?
|
| Pyridines | 3 | 2021 | 2825 | 0.150 |
Why?
|
| Leukoaraiosis | 2 | 2009 | 120 | 0.150 |
Why?
|
| Status Epilepticus | 1 | 2003 | 444 | 0.150 |
Why?
|
| Carotid Artery Injuries | 1 | 1998 | 96 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 3760 | 0.150 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2017 | 102 | 0.150 |
Why?
|
| Fatal Outcome | 3 | 2009 | 1850 | 0.140 |
Why?
|
| Causality | 5 | 2011 | 1275 | 0.140 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2018 | 365 | 0.140 |
Why?
|
| Motor Activity | 3 | 2018 | 2714 | 0.140 |
Why?
|
| Fibrinolytic Agents | 3 | 2016 | 2158 | 0.130 |
Why?
|
| Cohort Studies | 12 | 2018 | 40561 | 0.130 |
Why?
|
| Neuronal Plasticity | 4 | 2013 | 1422 | 0.130 |
Why?
|
| Perfusion | 2 | 2012 | 1360 | 0.130 |
Why?
|
| Functional Laterality | 4 | 2012 | 2290 | 0.130 |
Why?
|
| Methylprednisolone | 1 | 2016 | 387 | 0.130 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2021 | 489 | 0.130 |
Why?
|
| Logistic Models | 6 | 2023 | 13408 | 0.130 |
Why?
|
| Embolism | 1 | 2018 | 408 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2019 | 476 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2019 | 730 | 0.130 |
Why?
|
| Comorbidity | 6 | 2017 | 10388 | 0.130 |
Why?
|
| Regression Analysis | 5 | 2016 | 6459 | 0.120 |
Why?
|
| Diabetes Complications | 2 | 2020 | 1359 | 0.120 |
Why?
|
| Rats | 13 | 2013 | 24260 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1588 | 0.120 |
Why?
|
| Vertebral Artery | 1 | 1995 | 192 | 0.120 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 1073 | 0.120 |
Why?
|
| Movement | 2 | 2014 | 1471 | 0.120 |
Why?
|
| Blood Volume | 2 | 2012 | 565 | 0.120 |
Why?
|
| Patient Admission | 2 | 2020 | 1380 | 0.120 |
Why?
|
| Risk Assessment | 8 | 2020 | 23338 | 0.110 |
Why?
|
| Glyburide | 1 | 2014 | 113 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2018 | 8301 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 3255 | 0.110 |
Why?
|
| Mandible | 1 | 1998 | 740 | 0.110 |
Why?
|
| Hospital Mortality | 4 | 2021 | 5317 | 0.110 |
Why?
|
| Case-Control Studies | 5 | 2020 | 21746 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 2002 | 1197 | 0.110 |
Why?
|
| Vision Disorders | 4 | 2017 | 1058 | 0.110 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 941 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2014 | 638 | 0.110 |
Why?
|
| Aspirin | 2 | 2022 | 3282 | 0.110 |
Why?
|
| Osteotomy | 1 | 1998 | 822 | 0.100 |
Why?
|
| Cesarean Section | 1 | 2021 | 1365 | 0.100 |
Why?
|
| Arteriovenous Malformations | 1 | 1995 | 396 | 0.100 |
Why?
|
| Emergency Service, Hospital | 3 | 2022 | 7659 | 0.100 |
Why?
|
| Managed Care Programs | 1 | 2018 | 950 | 0.100 |
Why?
|
| Basilar Artery | 2 | 2012 | 200 | 0.100 |
Why?
|
| Hematologic Tests | 1 | 2013 | 240 | 0.100 |
Why?
|
| Rats, Wistar | 2 | 2012 | 1901 | 0.100 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 383 | 0.100 |
Why?
|
| Nimodipine | 1 | 2010 | 55 | 0.100 |
Why?
|
| Hospitals | 3 | 2019 | 3952 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 2886 | 0.100 |
Why?
|
| Disease Management | 2 | 2019 | 2459 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4933 | 0.090 |
Why?
|
| Heart Rate | 1 | 2022 | 4091 | 0.090 |
Why?
|
| Secondary Prevention | 2 | 2016 | 1530 | 0.090 |
Why?
|
| Telemedicine | 2 | 2021 | 2872 | 0.090 |
Why?
|
| Physician's Role | 1 | 2017 | 943 | 0.090 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.090 |
Why?
|
| Verapamil | 1 | 2010 | 244 | 0.090 |
Why?
|
| Multivariate Analysis | 4 | 2014 | 12245 | 0.090 |
Why?
|
| Gravitation | 1 | 2009 | 82 | 0.090 |
Why?
|
| Administration, Oral | 2 | 2023 | 3913 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2020 | 7729 | 0.090 |
Why?
|
| Neurology | 1 | 2017 | 763 | 0.090 |
Why?
|
| Hypoglycemic Agents | 2 | 2014 | 2872 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 2 | 2004 | 642 | 0.090 |
Why?
|
| Triage | 1 | 2016 | 976 | 0.090 |
Why?
|
| Prevalence | 5 | 2018 | 15226 | 0.090 |
Why?
|
| Aphasia | 1 | 2010 | 179 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 1536 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 1912 | 0.080 |
Why?
|
| Critical Care | 2 | 2020 | 2647 | 0.080 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2021 | 339 | 0.080 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2010 | 188 | 0.080 |
Why?
|
| Hemodynamics | 3 | 2020 | 4199 | 0.080 |
Why?
|
| Robotics | 2 | 2013 | 899 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 3068 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2015 | 2305 | 0.080 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 445 | 0.080 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2008 | 114 | 0.080 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 18029 | 0.080 |
Why?
|
| Iodine | 1 | 2009 | 286 | 0.080 |
Why?
|
| Mortality | 2 | 2016 | 2864 | 0.070 |
Why?
|
| Arteries | 2 | 2022 | 1119 | 0.070 |
Why?
|
| Vasculitis | 1 | 2011 | 519 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6895 | 0.070 |
Why?
|
| United States | 7 | 2022 | 69872 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2014 | 8324 | 0.070 |
Why?
|
| Double-Blind Method | 5 | 2021 | 12026 | 0.070 |
Why?
|
| Spinal Cord | 1 | 1995 | 1809 | 0.070 |
Why?
|
| International Normalized Ratio | 1 | 2008 | 367 | 0.070 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 1130 | 0.070 |
Why?
|
| Anatomy, Artistic | 1 | 2006 | 52 | 0.070 |
Why?
|
| Animals | 18 | 2018 | 168757 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 39050 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1519 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2010 | 6365 | 0.070 |
Why?
|
| Sex Factors | 2 | 2019 | 10397 | 0.070 |
Why?
|
| Telencephalon | 1 | 2007 | 142 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2011 | 818 | 0.070 |
Why?
|
| Haloperidol | 1 | 1988 | 397 | 0.070 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 977 | 0.070 |
Why?
|
| Medical Illustration | 1 | 2006 | 133 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2007 | 2899 | 0.070 |
Why?
|
| Nitric Oxide Donors | 1 | 2006 | 121 | 0.070 |
Why?
|
| Leukocytosis | 1 | 2007 | 247 | 0.070 |
Why?
|
| Education, Medical | 1 | 2017 | 1721 | 0.070 |
Why?
|
| Blood-Brain Barrier | 2 | 2002 | 1017 | 0.070 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 520 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3327 | 0.070 |
Why?
|
| Neurocysticercosis | 1 | 2006 | 62 | 0.060 |
Why?
|
| Accident Proneness | 1 | 2004 | 4 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2018 | 2788 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2007 | 719 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2007 | 576 | 0.060 |
Why?
|
| Thrombocytopenia | 2 | 2017 | 1179 | 0.060 |
Why?
|
| Odds Ratio | 5 | 2021 | 9849 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2017 | 9146 | 0.060 |
Why?
|
| Survival Rate | 2 | 2017 | 12788 | 0.060 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 4149 | 0.060 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 1917 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 6364 | 0.060 |
Why?
|
| Models, Animal | 2 | 2011 | 2171 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 1956 | 0.060 |
Why?
|
| Head | 1 | 2009 | 880 | 0.060 |
Why?
|
| Inpatients | 1 | 2015 | 2518 | 0.060 |
Why?
|
| Angiography | 1 | 2009 | 1639 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7181 | 0.060 |
Why?
|
| Cranial Sinuses | 1 | 2024 | 66 | 0.060 |
Why?
|
| Intracranial Pressure | 1 | 2006 | 326 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 3 | 2011 | 242 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 1995 | 1912 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2008 | 921 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2010 | 1826 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2009 | 6256 | 0.050 |
Why?
|
| Crohn Disease | 1 | 1995 | 2303 | 0.050 |
Why?
|
| Observer Variation | 4 | 2012 | 2593 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 690 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2002 | 237 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2007 | 737 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2007 | 1133 | 0.050 |
Why?
|
| Ephedrine | 1 | 2002 | 54 | 0.050 |
Why?
|
| Cerebral Cortex | 3 | 2011 | 5708 | 0.050 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2002 | 171 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9856 | 0.050 |
Why?
|
| Review Literature as Topic | 1 | 2004 | 336 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6882 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2015 | 3114 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 244 | 0.050 |
Why?
|
| Hospitalization | 2 | 2018 | 10262 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2282 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 1525 | 0.050 |
Why?
|
| Huntington Disease | 1 | 1988 | 1124 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2023 | 629 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 652 | 0.050 |
Why?
|
| Craniotomy | 1 | 2004 | 729 | 0.040 |
Why?
|
| Infusions, Intravenous | 3 | 2014 | 2274 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 9959 | 0.040 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.040 |
Why?
|
| Hippocampus | 1 | 2012 | 3675 | 0.040 |
Why?
|
| Brain Injuries | 2 | 2002 | 2025 | 0.040 |
Why?
|
| Cerebellum | 3 | 2013 | 1488 | 0.040 |
Why?
|
| Age Distribution | 4 | 2011 | 2902 | 0.040 |
Why?
|
| Contrast Sensitivity | 1 | 2001 | 244 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2002 | 381 | 0.040 |
Why?
|
| Hemorrhage | 2 | 2021 | 3461 | 0.040 |
Why?
|
| Movement Disorders | 2 | 2015 | 445 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2013 | 6442 | 0.040 |
Why?
|
| American Heart Association | 1 | 2024 | 1056 | 0.040 |
Why?
|
| Quality of Life | 2 | 2023 | 12804 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5751 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1518 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2016 | 14722 | 0.040 |
Why?
|
| Glycopeptides | 1 | 2000 | 224 | 0.040 |
Why?
|
| Length of Stay | 2 | 2018 | 6309 | 0.040 |
Why?
|
| Phlebography | 1 | 1999 | 333 | 0.040 |
Why?
|
| Troponin T | 1 | 2023 | 754 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2009 | 2149 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.040 |
Why?
|
| Prognathism | 1 | 1998 | 26 | 0.040 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1998 | 53 | 0.040 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1998 | 148 | 0.040 |
Why?
|
| New England | 1 | 2021 | 1022 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2023 | 859 | 0.040 |
Why?
|
| Asia, Western | 1 | 2017 | 20 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 6622 | 0.040 |
Why?
|
| Bone Marrow Examination | 1 | 2017 | 157 | 0.040 |
Why?
|
| Heart Atria | 1 | 2023 | 1357 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2017 | 188 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2011 | 3507 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1285 | 0.040 |
Why?
|
| Anemia, Hemolytic | 1 | 2017 | 168 | 0.040 |
Why?
|
| Poisoning | 1 | 1998 | 249 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 1 | 1999 | 337 | 0.040 |
Why?
|
| PubMed | 1 | 2017 | 123 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2000 | 880 | 0.040 |
Why?
|
| Aminosalicylic Acids | 1 | 1995 | 37 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1907 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2002 | 1221 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2002 | 1133 | 0.030 |
Why?
|
| Child | 6 | 2011 | 77709 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1995 | 94 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2618 | 0.030 |
Why?
|
| Sex Distribution | 3 | 2011 | 2297 | 0.030 |
Why?
|
| Microcirculation | 2 | 2011 | 1286 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
| Maxilla | 1 | 1998 | 470 | 0.030 |
Why?
|
| Mesalamine | 1 | 1995 | 136 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1127 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1526 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1392 | 0.030 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 19905 | 0.030 |
Why?
|
| Aging | 2 | 2011 | 8664 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2017 | 537 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6473 | 0.030 |
Why?
|
| Insulin | 1 | 2009 | 6580 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2017 | 404 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1995 | 341 | 0.030 |
Why?
|
| Rehabilitation Centers | 1 | 2015 | 254 | 0.030 |
Why?
|
| Rupture | 1 | 1995 | 433 | 0.030 |
Why?
|
| Suicide | 2 | 2002 | 1477 | 0.030 |
Why?
|
| Nutritional Support | 1 | 1995 | 168 | 0.030 |
Why?
|
| Suicide, Attempted | 1 | 2002 | 1221 | 0.030 |
Why?
|
| North America | 1 | 2017 | 1249 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2838 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2022 | 1491 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 3610 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6756 | 0.030 |
Why?
|
| Patient Discharge | 2 | 2016 | 3313 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 2009 | 930 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
| Epilepsy | 1 | 2008 | 3310 | 0.030 |
Why?
|
| Peptic Ulcer | 1 | 2014 | 223 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2008 | 6150 | 0.030 |
Why?
|
| Algorithms | 3 | 2009 | 13881 | 0.030 |
Why?
|
| Dysarthria | 1 | 2012 | 57 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2009 | 957 | 0.030 |
Why?
|
| Incidence | 4 | 2017 | 20947 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 2400 | 0.030 |
Why?
|
| Radiography | 2 | 2013 | 7023 | 0.030 |
Why?
|
| Developing Countries | 2 | 2008 | 2815 | 0.030 |
Why?
|
| Spleen | 1 | 2017 | 2362 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2017 | 1063 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2002 | 3086 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2008 | 41006 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2006 | 6669 | 0.020 |
Why?
|
| Water | 2 | 2011 | 1395 | 0.020 |
Why?
|
| Veins | 1 | 1995 | 770 | 0.020 |
Why?
|
| Hand Strength | 1 | 2014 | 448 | 0.020 |
Why?
|
| Neck | 1 | 1995 | 697 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 522 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3339 | 0.020 |
Why?
|
| Ataxia | 1 | 2012 | 304 | 0.020 |
Why?
|
| Anisotropy | 1 | 2014 | 1265 | 0.020 |
Why?
|
| Age Factors | 3 | 2015 | 18370 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2569 | 0.020 |
Why?
|
| Steroids | 1 | 1995 | 930 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 7279 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2009 | 195 | 0.020 |
Why?
|
| Echocardiography | 1 | 2002 | 5102 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 2429 | 0.020 |
Why?
|
| Hepatitis C | 1 | 1999 | 1591 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 4462 | 0.020 |
Why?
|
| Brain Damage, Chronic | 1 | 2010 | 265 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8642 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2119 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 195 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
| Anemia | 1 | 2017 | 1506 | 0.020 |
Why?
|
| Neuroradiography | 1 | 2008 | 70 | 0.020 |
Why?
|
| Disopyramide | 1 | 1987 | 16 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2011 | 546 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 571 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
| Infant | 2 | 2008 | 35136 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 1988 | 374 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 8863 | 0.020 |
Why?
|
| Iopamidol | 1 | 2007 | 191 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 683 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2014 | 5102 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1994 | 1018 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1590 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2010 | 712 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 25043 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1995 | 1790 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2011 | 1116 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2020 | 8554 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15295 | 0.020 |
Why?
|
| Liver | 1 | 2000 | 7474 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 1863 | 0.010 |
Why?
|
| Atmospheric Pressure | 1 | 2003 | 47 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13695 | 0.010 |
Why?
|
| Ontario | 1 | 2004 | 383 | 0.010 |
Why?
|
| Hand | 1 | 2009 | 884 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2015 | 3589 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 2278 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 472 | 0.010 |
Why?
|
| Forelimb | 1 | 2003 | 122 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 9338 | 0.010 |
Why?
|
| Health Status | 1 | 2015 | 4034 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4468 | 0.010 |
Why?
|
| Amyloidosis | 1 | 2008 | 795 | 0.010 |
Why?
|
| Hypercapnia | 1 | 2003 | 260 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2008 | 1547 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 1014 | 0.010 |
Why?
|
| Data Collection | 1 | 2010 | 3341 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2009 | 1774 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2011 | 2585 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2000 | 222 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2373 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 845 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5319 | 0.010 |
Why?
|
| ROC Curve | 1 | 2007 | 3527 | 0.010 |
Why?
|
| Trauma Centers | 1 | 2004 | 890 | 0.010 |
Why?
|
| Pain | 1 | 1994 | 4986 | 0.010 |
Why?
|
| Flavonoids | 1 | 2002 | 443 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 2505 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2008 | 1916 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.010 |
Why?
|
| Safety | 1 | 2003 | 1186 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 2252 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2009 | 2972 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11366 | 0.010 |
Why?
|
| Medicare | 1 | 2015 | 6566 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2013 | 4687 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 3336 | 0.010 |
Why?
|
| Linear Models | 1 | 2007 | 5952 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8663 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 2021 | 0.010 |
Why?
|
| Imidazoles | 1 | 2002 | 1206 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2002 | 19229 | 0.010 |
Why?
|
| Plasmids | 1 | 2000 | 2307 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 1881 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1994 | 162 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 5300 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 5078 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2001 | 1071 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 2010 | 15165 | 0.010 |
Why?
|
| Urination Disorders | 1 | 1994 | 241 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2008 | 4558 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5882 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3798 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1994 | 772 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 1994 | 551 | 0.010 |
Why?
|
| Cough | 1 | 1994 | 555 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1994 | 416 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 25625 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13815 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1994 | 3508 | 0.000 |
Why?
|
| Research Design | 1 | 2003 | 5987 | 0.000 |
Why?
|
| Gene Expression | 1 | 2000 | 7799 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 18111 | 0.000 |
Why?
|
| Fever | 1 | 1994 | 1616 | 0.000 |
Why?
|
| Tachycardia | 1 | 1987 | 619 | 0.000 |
Why?
|
| Pulmonary Edema | 1 | 1987 | 414 | 0.000 |
Why?
|
| Mice | 2 | 2002 | 81183 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 21827 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1994 | 2708 | 0.000 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1994 | 3022 | 0.000 |
Why?
|